Valuation : CTT Pharmaceutical Holdings, Inc.

Market Cap 3.03M 2.6M 2.45M 2.24M 4.17M 287M 4.2M 29.04M 11.23M 147M 11.38M 11.13M 467M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 3.03M 2.61M 2.45M 2.24M 4.18M 288M 4.2M 29.07M 11.25M 147M 11.39M 11.14M 468M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
1 day-8.75%
1 week+46.00%
Current month+49.68%
1 month+10.61%
3 months-6.29%
6 months-6.29%
Current year+21.45%
1 week 0.04
Extreme 0.0449
0.07
1 month 0.04
Extreme 0.0401
0.07
Current year 0.04
Extreme 0.0401
0.1
1 year 0.04
Extreme 0.035
0.1
3 years 0
Extreme 0.0031
0.15
5 years 0
Extreme 0.003
0.15
10 years 0
Extreme 0.003
2.17
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 A BuyCompany 9,800 0.0167%
9/2/26 A BuyCompany 3,000 0.0051%
8/31/26 A BuyCompany 3,500 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
-8.75%+46.00%+82.50%+729.55% 3.03M
-2.75%-7.30%-4.86%+11.00% 48.01B
+0.89%+0.07%+411.42%+536.98% 44.44B
-1.32%-3.03%+34.91%+18.82% 42.67B
-0.65%-3.42%-0.50%+66.98% 39.96B
0.00%-2.61%+13.09%+42.33% 32.75B
-2.35%-1.26% - - 17.74B
-1.04%-1.86%+19.85%+108.34% 16.49B
-0.37%-2.53%+10.91%+30.93% 14.38B
-0.68%-4.84%+76.42%+39.06% 13.4B
Average -1.64%-0.48%+71.53%+176.00% 26.98B
Weighted average by Cap. -0.86%-1.10%+85.11%+126.98%

Financials

2024 2025
Net sales - -
Net income -250K -215K -202K -185K -345K -23.72M -346K -2.4M -928K -12.13M -940K -919K -38.59M -156K -134K -126K -115K -215K -14.78M -216K -1.49M -578K -7.55M -585K -573K -24.04M
Net Debt 16.82K 14.46K 13.6K 12.42K 23.17K 1.59M 23.29K 161K 62.36K 815K 63.16K 61.78K 2.59M 3.46K 2.97K 2.79K 2.55K 4.76K 328K 4.78K 33.11K 12.81K 167K 12.97K 12.69K 533K
Logo CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-
Date Price Change Volume
08/09/26 $0.0516 +6.46% 31,518
04/09/26 $0.0485 -3.06% 8,960
03/09/26 $0.0500 +2.27% 27,030
02/09/26 $0.0489 -2.22% 32,575
01/09/26 $0.0500 +2.52% 43,000
  1. Stock Market
  2. Stocks
  3. CTTH Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!